Results of the m-RESIST feasibility study. A Mobile therapeutic attention for treatment-resistant schizophrenia
In the European Union between 0.2 and 2.6% of the population suffer from psychotic disorders, and around 40% can be considered resistant to pharmacological treatment [1]. Interventions based on m-Health solutions may be effective in increasing treatment adherence, relieving some of the symptoms of s...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Ubiquity Press
2019-08-01
|
Series: | International Journal of Integrated Care |
Subjects: | |
Online Access: | https://www.ijic.org/articles/4756 |